Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
PreprintAll rights reservedbioRxiv

Glutamine and GLS1 are key metabolic checkpoints that Limit T cell Infiltration and Function in HNSCC

  • S. M. Decking-Paede
  • I. Ugele
  • K. Dettmer
  • G. Horkovics-Kovats
  • J. Kuenzel
  • C. Zuur
  • J. Traits
  • C. Korf
  • J. Todt
  • F. Kellermeier
  • L. Voelkl
  • T. Zierul
29 more authors
  • A. Hehemann
  • F. Westphal
  • H. Wenzel
  • S. Wittmann
  • L. Stengel
  • S. Loipfinger
  • C. Schmidl
  • V. M. Milenkovic
  • E. Paddenberg-Schubert
  • A. Schroeder
  • A. K. Wege
  • J. A. Hutchinson
  • P. Riquelme
  • C. Bruss
  • L. Symeou
  • T. Ettl
  • I. Michaelides
  • M. Kapsreiter
  • M. Rink
  • F. Weber
  • D. Simon
  • I. Pap
  • J. S. McKenzie
  • Y. Xiang
  • C. Bohr
  • P. J. Oefner
  • M. Kreutz
  • Z. Takats
  • K. Renner1
  1. 1University Hospital Regensburg
Read full textPDFDOICite

Related

  1. Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma
    Shuyuan Zhang, Polly J. Phillips-Mason, Bartosz Mucha +9
    Cancer researchPeer-reviewedLicence not statedFull textOncologyPMC
  2. The glutamine-aspartate metabolic tradeoff between fast growth and metabolic flexibility
    Karin Ortmayr, Meret Ringwald, Laurentz Schuhknecht +8
    Genome BiologyPeer-reviewedCC BY 4.0OncologyCrossref
  3. Tip60‐Mediated USP22 Lactylation Drives Glutamine Metabolic Reprogramming via SLC25A5 in TNBC
    Fang Zhen, Hongyi Wang, Ningzhi Zhang +5
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Mitochondrial metabolic reprogramming by a glutamine antagonist radioenhancer conjugate drives pyroptosis and antitumor immunity
    Rundi Song, Jinhong Li, Chaoyu Wang +6
    Science AdvancesPeer-reviewedCC BY-NCFull textGeneral chemistryOncologySci. Adv.CrossrefEurope PMCEurope PMC+1
  5. Construction of a five-gene prognostic model involving T cell exhaustion and metabolic reprogramming for predicting hepatocellular carcinoma risk using LASSO: insights into immune infiltration and drug sensitivity
    Shaogang Wang, Ying Chen, Yu Mao +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@misc{deckingpaede2026glutamine,
  title = {{Glutamine and GLS1 are key metabolic checkpoints that Limit T cell Infiltration and Function in HNSCC}},
  author = {S. M. Decking-Paede and I. Ugele and K. Dettmer and G. Horkovics-Kovats and J. Kuenzel and C. Zuur and J. Traits and C. Korf and J. Todt and F. Kellermeier and L. Voelkl and T. Zierul and A. Hehemann and F. Westphal and H. Wenzel and S. Wittmann and L. Stengel and S. Loipfinger and C. Schmidl and V. M. Milenkovic and E. Paddenberg-Schubert and A. Schroeder and A. K. Wege and J. A. Hutchinson and P. Riquelme and C. Bruss and L. Symeou and T. Ettl and I. Michaelides and M. Kapsreiter and M. Rink and F. Weber and D. Simon and I. Pap and J. S. McKenzie and Y. Xiang and C. Bohr and P. J. Oefner and M. Kreutz and Z. Takats and K. Renner},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.753717},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.753717v1},
}
RIS
TY  - UNPB
TI  - Glutamine and GLS1 are key metabolic checkpoints that Limit T cell Infiltration and Function in HNSCC
AU  - S. M. Decking-Paede
AU  - I. Ugele
AU  - K. Dettmer
AU  - G. Horkovics-Kovats
AU  - J. Kuenzel
AU  - C. Zuur
AU  - J. Traits
AU  - C. Korf
AU  - J. Todt
AU  - F. Kellermeier
AU  - L. Voelkl
AU  - T. Zierul
AU  - A. Hehemann
AU  - F. Westphal
AU  - H. Wenzel
AU  - S. Wittmann
AU  - L. Stengel
AU  - S. Loipfinger
AU  - C. Schmidl
AU  - V. M. Milenkovic
AU  - E. Paddenberg-Schubert
AU  - A. Schroeder
AU  - A. K. Wege
AU  - J. A. Hutchinson
AU  - P. Riquelme
AU  - C. Bruss
AU  - L. Symeou
AU  - T. Ettl
AU  - I. Michaelides
AU  - M. Kapsreiter
AU  - M. Rink
AU  - F. Weber
AU  - D. Simon
AU  - I. Pap
AU  - J. S. McKenzie
AU  - Y. Xiang
AU  - C. Bohr
AU  - P. J. Oefner
AU  - M. Kreutz
AU  - Z. Takats
AU  - K. Renner
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.753717
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.753717v1
ER  -